TLIS logo

Talis Biomedical (TLIS) EBIT

Annual EBIT

-$66.81 M
+$48.32 M+41.97%

31 December 2023

TLIS EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

-$9.58 M
+$4.54 M+32.15%

30 June 2024

TLIS Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

-$55.12 M
+$6.81 M+11.00%

30 June 2024

TLIS TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TLIS EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+33.7%+17.5%
3 y3 years+65.2%+66.4%+71.3%
5 y5 years-150.3%-39.6%-703.2%

TLIS EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+65.2%at high+75.1%at high+73.4%
5 y5 years-211.8%+65.2%-39.6%+85.1%-703.2%+73.4%
alltimeall time-211.8%+65.2%-39.6%+85.1%-703.2%+73.4%

Talis Biomedical EBIT History

DateAnnualQuarterlyTTM
June 2024
-
-$9.58 M(-32.2%)
-$55.12 M(-11.0%)
Mar 2024
-
-$14.12 M(-2.3%)
-$61.94 M(-7.3%)
Dec 2023
-$66.81 M(-42.0%)
-$14.46 M(-14.8%)
-$66.81 M(-17.0%)
Sept 2023
-
-$16.97 M(+3.5%)
-$80.47 M(-10.9%)
June 2023
-
-$16.39 M(-13.7%)
-$90.29 M(-10.8%)
Mar 2023
-
-$19.00 M(-32.4%)
-$101.17 M(-12.1%)
Dec 2022
-$115.14 M(-40.0%)
-$28.11 M(+5.0%)
-$115.14 M(-0.4%)
Sept 2022
-
-$26.79 M(-1.8%)
-$115.55 M(-9.1%)
June 2022
-
-$27.27 M(-17.3%)
-$127.17 M(-22.6%)
Mar 2022
-
-$32.97 M(+15.6%)
-$164.26 M(-14.4%)
DateAnnualQuarterlyTTM
Dec 2021
-$191.82 M(+110.4%)
-$28.52 M(-25.8%)
-$191.82 M(-7.5%)
Sept 2021
-
-$38.41 M(-40.3%)
-$207.48 M(+4.4%)
June 2021
-
-$64.36 M(+6.3%)
-$198.65 M(+37.7%)
Mar 2021
-
-$60.52 M(+37.0%)
-$144.31 M(+58.3%)
Dec 2020
-$91.18 M(+241.5%)
-$44.18 M(+49.3%)
-$91.18 M(+69.3%)
Sept 2020
-
-$29.58 M(+195.1%)
-$53.87 M(+121.8%)
June 2020
-
-$10.02 M(+35.6%)
-$24.28 M(+70.3%)
Mar 2020
-
-$7.39 M(+7.8%)
-$14.26 M(+107.8%)
Dec 2019
-$26.70 M(+24.6%)
-$6.86 M
-$6.86 M
Dec 2018
-$21.43 M
-
-

FAQ

  • What is Talis Biomedical annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Talis Biomedical?
  • What is Talis Biomedical quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Talis Biomedical?
  • What is Talis Biomedical quarterly EBIT year-on-year change?
  • What is Talis Biomedical TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Talis Biomedical?
  • What is Talis Biomedical TTM EBIT year-on-year change?

What is Talis Biomedical annual earnings before interest & taxes?

The current annual EBIT of TLIS is -$66.81 M

What is the all time high annual EBIT for Talis Biomedical?

Talis Biomedical all-time high annual earnings before interest & taxes is -$20.78 M

What is Talis Biomedical quarterly earnings before interest & taxes?

The current quarterly EBIT of TLIS is -$9.58 M

What is the all time high quarterly EBIT for Talis Biomedical?

Talis Biomedical all-time high quarterly earnings before interest & taxes is -$6.86 M

What is Talis Biomedical quarterly EBIT year-on-year change?

Over the past year, TLIS quarterly earnings before interest & taxes has changed by +$4.88 M (+33.74%)

What is Talis Biomedical TTM earnings before interest & taxes?

The current TTM EBIT of TLIS is -$55.12 M

What is the all time high TTM EBIT for Talis Biomedical?

Talis Biomedical all-time high TTM earnings before interest & taxes is -$6.86 M

What is Talis Biomedical TTM EBIT year-on-year change?

Over the past year, TLIS TTM earnings before interest & taxes has changed by +$11.69 M (+17.50%)